Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term '1,3-diol' refers to a chemical structural motif characterized by the presence of two hydroxyl (-OH) groups attached to the first and third carbon atoms of a carbon chain. It is not a biological target, such as a receptor, enzyme, or transporter, but rather a class of organic compounds or a functional group arrangement within a molecule [1][3]. Common examples include 1,3-propanediol, used primarily in industrial applications, and 1,3-butanediol, which serves as a metabolic precursor to the ketone body beta-hydroxybutyrate in physiological contexts [2][4]. In medicinal chemistry, 1,3-diol units are frequently synthesized as structural components of complex natural products or synthetic drugs to influence pharmacokinetics and binding orientation, but the motif itself is not a therapeutic target [5]. Because it describes a chemical class rather than a specific protein or gene product, it does not possess a mechanism of action or associated disease roles in a clinical pharmacology sense.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1,3-Diol.